Le Lézard
Classified in: Health, Science and technology, Business
Subject: BFA

Introducing Scripta Insights, the Healthcare Tech Company Disrupting the $300B Pharmacy Benefits Industry

WELLESLEY, Mass., Jan. 21, 2020 /PRNewswire/ -- The state of the prescription drug market in America has reached a crisis point. 28% of Americans are on high deductible health plans. 26% of Americans report not taking the drugs they need because they can't afford to buy them. Self-insured companies struggle to offer the level of benefits their employees need at a price they can afford. Health plans have to keep raising prices in order to keep up with the costs of prescription drug coverage.

At the root of this problem is a complex and layered prescription drug marketplace which is shockingly confusing and hard to navigate. The true prices of the important drugs people take daily are nearly always unclear to every party involved. The market is classically asymmetrical with the suppliers dictating the market dynamics and the buyers (companies, healthplans, and patients) all at the mercy of a market that changes every day, and requires deep expertise to understand. 

Meet Scripta Insights, a healthcare IT solution that's bringing transparency to the prescription drug market and finding 46% savings opportunities for payers.

Scripta was originally developed by a doctor, Paul Bradley, who was frustrated by the high cost of prescription drugs and the impact this had on his patients.

As a physician, he rarely had insight into how much a certain medication would cost his patients. Making matters worse, his patients didn't discover the price of the medication until they filled it at the pharmacy, leading to many patients making difficult budgetary decisions that may be detrimental to their health. Finally, payers, who are partially or entirely funding the member's prescription drug, don't know their share of the cost until 45 days after the purchase is made when their PBM bill arrives.

Working with his wife, a CPA, Dr. Bradley recruited other physicians in every specialty, and began to devise strategies for their patients to save money on prescription drugs, and to code these strategies into a database. Led by Mrs. Mindy Bradley, this effort eventually grew into Script.AI, a powerful software that uses advanced analytics & AI to solve the "big data" challenge that is pharmacy benefits.

"Technology has proven time and again to be the great leveler of the playing field.  By using technology to bring unprecedented transparency to the pharmacy benefit market, on average, Scripta is able to identify a 46% savings opportunity for payers," said Eric Levin, CEO, Scripta Insights. "In the first half of 2019 alone, there were more than 4,400 price increases on prescription drugs, compared to just 46 price decreases. The market is complex and requires intense knowledge of medicine and pharmacy. Our advanced technology tools are capable of staying on top of this rapidly evolving market, allowing payers to take control of their pharmacy benefit spend, every member, every transaction, every day."

Scripta's software enables three key advances in pharmacy benefit cost containment:

  1. PBM Optimization: Scripta's software breaks down pharmacy spend into 27 actionable categories to enable payers to have educated discussions and enhanced negotiations with their PBM partner to find every opportunity to control costs.
  2. Data Driven Plan Design: Once a company better understands its population and its drug utilization, a payer can make changes to their plan design to best align incentives and reduce costs.  Rather than just benchmarking to similar companies, payers get completely customized plan design based on data insights.
  3. Member Savings Benefits: Scripta provides customized reporting with intelligent recommendations and savings strategies to members so that they can have informed discussions with their doctor about their treatment options and the cost impact of different choices.

Scripta maintains a Pharmacy & Theraputics (P&T) Committee of more than 25 doctors and pharmacists who review and advise on medications and potential substitutions. They inform and constantly update their proprietary Medicine Mapping & Pricing Database?enabling Scripta's customers to have the transparency and expertise needed to become better, smarter buyers of pharmacy benefits and prescription drugs.

For more information about Scripta Insights, visit www.scriptainsights.com.

About Scripta Insights

Scripta Insights, a company founded by doctors, is using technology to create transparency, disrupt and improve the $300B self-funded pharmacy benefits marketplace.

Scripta is a healthcare IT solution that delivers immediate, real savings on pharmacy benefit costs for self-insured employers, payers and their members. It empowers companies to take control of their pharmacy spend, while helping members get the medicine they need at the best possible price.

Scripta's proprietary software, Script.AI, was developed over a decade and is designed to analyze millions of pharmacy transactions in mere seconds to yield actionable insights. It uses data analytics, AI and expert insights from its P&T Committee to recognize savings opportunities that, until now, have been impossible to identify. 

Scripta has saved employers and members millions of dollars on prescriptions.

For more information about Scripta, visit www.scriptainsights.com.

SOURCE Scripta Insights

These press releases may also interest you

at 03:15
"LA Mansion Prince Painted Purple For Sale" It may have been the most infamous house-painting job in Los Angeles history in 2005 when mega-rocker-star Prince painted NBA-star Carlos Boozer's Beverly Hills home in purple stripes. New to the market,...

at 03:05
StabiLens, based out of Potsdam, New York, has launched a brand-new website and ecommerce shop at stabilens.com. It offers customers the chance to learn about and order the Stabilens Gimbal Ring System -- A first of its kind camera attachment that...

at 03:00
ASE Technology Holding Co., Ltd. , announces its unaudited consolidated net revenues for March and 1st quarter of 2020. CONSOLIDATED NET REVENUES (UNAUDITED) Mar Feb Mar Sequential YoY (NT$ Million) 2020 2020 2019 Change Change Net Revenues 37,884...

at 03:00
The American Council of Learned Societies (ACLS) is pleased to announce the 2020 cohort of ACLS Fellows. The largest and longest running program in the organization's portfolio, the ACLS Fellowship program honors scholars in the humanities and...

at 02:09
Barbuto & Johansson, P.A. ("BARJO") and Of Counsel, Neil Rothstein, Esq. (with over 30 years of Securities Class Action Experience, including cases against ENRON and Halliburton) informs investors that a class action lawsuit has been filed, expanding...

at 02:00
iwoca research shows that British public is significantly more sympathetic towards the struggles of small businesses compared to large companies (21%)  However, nearly 70% would not use small businesses if they could save just £1 by buying from a...

News published on 21 january 2020 at 09:05 and distributed by: